Rajeswaran Mani

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 3

Top Topics

Cell Cycle Arrest

Epithelial Mesenchymal Transition

Acute Lymphoblastic Leukemia

Top Venues

Science signaling

Molecular cancer therapeutics

Ohio State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Ohio State University

United States

PHD

Publications

Marco H Hofmann, Rajeswaran Mani, Harald Engelhardt, Maria A Impagnatiello, Sebastian Carotta, Marc Kerenyi, Seila Lorenzo-Herrero, Jark Böttcher, Dirk Scharn, Heribert Arnhof, Andreas Zoephel, Renate Schnitzer, Thomas Gerstberger, Michael P Sanderson, Girish Rajgolikar, Swagata Goswami, Sumithira Vasu, Peter Ettmayer, Segundo González, Mark Pearson, Darryl B McConnell, Norbert Kraut, Natarajan Muthusamy, Jürgen Moll
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance. Molecular cancer therapeutics 19 (4) (2020)
Chi-Ling Chiang, Swagata Goswami, Frank W Frissora, Zhiliang Xie, Pearlly S Yan, Ralf Bundschuh, Logan A Walker, Xiaomeng Huang, Rajeswaran Mani, Xiaokui M Mo, Sivasubramanian Baskar, Christoph Rader, Mitch A Phelps, Guido Marcucci, John C Byrd, L James Lee, Natarajan Muthusamy
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model. Blood 134 (5) (2019)
Kostandin V Pajcini, Lanwei Xu, Lijian Shao, Jelena Petrovic, Karol Palasiewicz, Yumi Ohtani, Will Bailis, Curtis Lee, Gerald B Wertheim, Rajeswaran Mani, Natarajan Muthusamy, Yunlei Li, Jules P P Meijerink, Stephen C Blacklow, Robert B Faryabi, Sara Cherry, Warren S Pear
MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia. Science signaling 10 (505) (2017)